Eupraxia Pharmaceuticals (EPRX) Interest Coverage Ratio (2023 - 2024)
Eupraxia Pharmaceuticals (EPRX) posted quarterly Interest Coverage Ratio of 908.88 for Q4 2025, down 17248.38% year-over-year from N/an in Q4 2024, and down 17248.38% quarter-over-quarter from 5.24 in Q4 2024.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Interest Coverage Ratio (2023 - 2024) Analysis & Trends
Eupraxia Pharmaceuticals (EPRX) has reported Interest Coverage Ratio for 3 consecutive years, with 908.88 the latest figure, recorded in Q4 2025.
- In Q4 2025, Interest Coverage Ratio fell 17248.38% year-over-year to 908.88; the TTM figure through Dec 2025 stood at 2100.09 (down 5402.53% YoY), while the FY2025 annual figure was 0.11, down 38.13% from the prior year.
- Interest Coverage Ratio retreated to 908.88 in Q4 2025 per EPRX's latest filing, from 5.24 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 13285.52 in Q3 2024 and bottomed at 908.88 in Q4 2025.
- Historically, Interest Coverage Ratio has averaged 2481.23 across 3 years, with a median of 14.57 in 2023.
- Annual changes were most pronounced in 2024 — Interest Coverage Ratio surged 38.32% — and 2025, when it tumbled 17248.38%.
- Eupraxia Pharmaceuticals' Interest Coverage Ratio stood at 14.57 in 2023, then slumped by 135.95% to 5.24 in 2024, then sank by 17248.38% to 908.88 in 2025.
- Business Quant data shows EPRX's Interest Coverage Ratio at 908.88 in Q4 2025, 5.24 in Q4 2024, and 13285.52 in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -21.24 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 1.42 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -0.08 |
| 10 | Eupraxia Pharmaceuticals | 305.07 Mn | 305.07 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 54,968.43 |
| Sep 30, 2024 | 13,285.52 |
| Jun 30, 2024 | 22.53 |
| Mar 31, 2024 | 20.16 |
| Jun 30, 2023 | 32.50 |
| Mar 31, 2023 | 14.57 |